172 related articles for article (PubMed ID: 17244226)
21. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA;
Retina; 2008; 28(10):1387-94. PubMed ID: 18827735
[TBL] [Abstract][Full Text] [Related]
22. Intravitreal bevacizumab (Avastin) in idiopathic retinitis, vasculitis, aneurysms and neuroretinitis.
Akesbi J; Brousseaud FX; Adam R; Rodallec T; Nordmann JP
Acta Ophthalmol; 2010 Mar; 88(2):e40-1. PubMed ID: 19508455
[No Abstract] [Full Text] [Related]
23. Early intravitreal bevacizumab for non-ischaemic central retinal vein occlusion.
Rensch F; Jonas JB; Spandau UH
Acta Ophthalmol; 2009 Feb; 87(1):77-81. PubMed ID: 18937800
[TBL] [Abstract][Full Text] [Related]
24. Herpetic epithelial keratitis after intravitreal injection of bevacizumab (avastin).
Khalili MR; Mehdizadeh M; Mehryar M
Cornea; 2009 Apr; 28(3):360-1. PubMed ID: 19387245
[TBL] [Abstract][Full Text] [Related]
25. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration in treatment-naive patients.
Pedersen KB; Sjølie AK; Møller F
Acta Ophthalmol; 2009 Nov; 87(7):714-9. PubMed ID: 19094171
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal bevacizumab injection for central serous chorioretinopathy.
Nowroozzadeh MH
Retina; 2010 Sep; 30(8):1322-3; author reply 1323. PubMed ID: 20827148
[No Abstract] [Full Text] [Related]
27. Intravitreal bevacizumab injection for central serous chorioretinopathy.
Chhablani JK; Narayanan R
Retina; 2010 Sep; 30(8):1323-24; author reply 1324. PubMed ID: 20661171
[No Abstract] [Full Text] [Related]
28. Preclinical safety evaluation of intravitreal injection of full-length humanized vascular endothelial growth factor antibody in rabbit eyes.
Inan UU; Avci B; Kusbeci T; Kaderli B; Avci R; Temel SG
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1773-81. PubMed ID: 17389511
[TBL] [Abstract][Full Text] [Related]
29. In vivo corneal endothelial safety of intracameral bevacizumab and effect in neovascular glaucoma combined with Ahmed valve implantation.
Shin JP; Lee JW; Sohn BJ; Kim HK; Kim SY
J Glaucoma; 2009; 18(8):589-94. PubMed ID: 19826387
[TBL] [Abstract][Full Text] [Related]
30. Intravitreal bevacizumab for branch retinal vein occlusion.
Spandau U; Wickenhäuser A; Rensch F; Jonas J
Acta Ophthalmol Scand; 2007 Feb; 85(1):118-9. PubMed ID: 17244225
[No Abstract] [Full Text] [Related]
31. Bevacizumab local complications.
Gordon-Angelozzi M; Velez-Montoya R; Fromow-Guerra J; García-Aguirre G; Guerrero-Naranjo JL; Quiroz-Mercado H; Morales-Cantón V
Ophthalmology; 2009 Nov; 116(11):2264.e1-3. PubMed ID: 19883862
[No Abstract] [Full Text] [Related]
32. Clinical predictors of sustained intraocular pressure elevation due to intravitreal anti-vascular endothelial growth factor therapy.
Hoang QV; Tsuang AJ; Gelman R; Mendonca LS; Della Torre KE; Jung JJ; Freund KB
Retina; 2013 Jan; 33(1):179-87. PubMed ID: 22990314
[TBL] [Abstract][Full Text] [Related]
33. Isolated sixth nerve palsy after intravitreal bevacizumab injection.
Cakmak HB; Toklu Y; Yorgun MA; Simşek S
Strabismus; 2010 Mar; 18(1):18-20. PubMed ID: 20230202
[TBL] [Abstract][Full Text] [Related]
34. Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.
Fakhraie G; Katz LJ; Prasad A; Eslami Y; Sabour S; Zarei R; Moghimi S
J Glaucoma; 2010 Mar; 19(3):212-8. PubMed ID: 19593201
[TBL] [Abstract][Full Text] [Related]
35. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration: a short-term study.
Chen CY; Wong TY; Heriot WJ
Am J Ophthalmol; 2007 Mar; 143(3):510-2. PubMed ID: 17317398
[TBL] [Abstract][Full Text] [Related]
36. Controversies in the treatment of wet age-related macular degeneration.
Moreno SF; Paloma JB
Am J Ophthalmol; 2008 May; 145(5):937; author reply 938. PubMed ID: 18435977
[No Abstract] [Full Text] [Related]
37. Intravitreal bevacizumab for retinal capillary haemangioma: longterm results.
Ach T; Thiemeyer D; Hoeh AE; Schaal KB; Dithmar S
Acta Ophthalmol; 2010 Jun; 88(4):e137-8. PubMed ID: 19681788
[No Abstract] [Full Text] [Related]
38. Angiographic changes after bevacizumab.
Ikuno Y; Soga K; Wakabayashi T; Gomi F
Ophthalmology; 2009 Nov; 116(11):2263.e1. PubMed ID: 19883861
[No Abstract] [Full Text] [Related]
39. Early loss of pregnancy after intravitreal bevacizumab injection.
Petrou P; Georgalas I; Giavaras G; Anastasiou E; Ntana Z; Petrou C
Acta Ophthalmol; 2010 Jun; 88(4):e136. PubMed ID: 19740128
[No Abstract] [Full Text] [Related]
40. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
Kumar V; Ghosh B; Raina UK; Goel N
Am J Ophthalmol; 2008 Dec; 146(6):974; author reply 974-5. PubMed ID: 19027427
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]